ALTERED BLOOD AND AQUEOUS HUMOR LEVELS OF ASPROSIN, 4-HYDROXYNONENAL, AND 8-HYDROXY-DEOXYGUANOSINE IN PATIENTS WITH DIABETES MELLITUS AND CATARACT WITH AND WITHOUT DIABETIC RETINOPATHY-Reference-Cited by-同舟云学术

ALTERED BLOOD AND AQUEOUS HUMOR LEVELS OF ASPROSIN, 4-HYDROXYNONENAL, AND 8-HYDROXY-DEOXYGUANOSINE IN PATIENTS WITH DIABETES MELLITUS AND CATARACT WITH AND WITHOUT DIABETIC RETINOPATHY

Published:2020-02-19 Issue:12 Volume:40 Page:2410-2416
ISSN:0275-004X
Container-title:Retina
language:en
Short-container-title:

Author:

Oruc Yavuz,Celik Fatih,Ozgur Gokhan,Beyazyildiz Emrullah,Ugur Kader,Yardim Meltem,Sahin Ibrahim,Akkoc Ramazan Fazil,Aydin Suleyman

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Ophthalmology,General Medicine

Reference29 articles.

1. Optimal treatment of diabetic retinopathy;Hammes;Ther Adv Endocrinol Metab,2013

2. Optical coherence tomography angiography in diabetes;Lee;Curr Diab Rep,2016

3. The diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: overview;Nathan;Diabetes Care,2014

4. The ageing lens and cataract: a model of normal and pathological ageing;Michael;Philos Trans R Soc Lond B Biol Sci,2011

5. Asprosin, a fasting-induced glucogenic protein hormone;Romere;Cell,2016

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Increased serum asprosin is correlated with diabetes mellitus-induced erectile dysfunction;Diabetology & Metabolic Syndrome;2024-04-24

2. The correlation between serum asprosin and left ventricular diastolic dysfunction in elderly patients with type 2 diabetes mellitus in the community;Journal of Diabetes Investigation;2024-02-16

3. Serum Amyloid A 4 as a Common Marker of Persistent Inflammation in Patients with Neovascular Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy;Journal of Inflammation Research;2023-08

4. Aldehyde Dehydrogenase and Aldo-Keto Reductase Enzymes: Basic Concepts and Emerging Roles in Diabetic Retinopathy;Antioxidants;2023-07-21

5. Can the new adipokine asprosin be a metabolic troublemaker for cardiovascular diseases? A state-of-the-art review;Progress in Lipid Research;2023-07